The CiTAS scale for evaluating taste alteration induced by chemotherapy: State of the art on its clinical use

Silvio Simeone, Maria Rosaria Esposito, Gianpaolo Gargiulo, Aniello Lanzuise, Stefano Botti, Nicola Serra, Grazia Isabella Continisio, Teresa Rea, Assunta Guillari

Research output: Contribution to journalArticle

Abstract

Background: Cancer is the leading cause of death worldwide. Of the various therapeutic approaches, chemotherapy is the most widely used treatment. Among the various side effects associated with this treatment, taste alterations (TAs) have received little attention, even though they have a serious impact on the nutritional aspect and quality of life (QoL) of patients. TAs concern 75% of the patients receiving chemotherapy, and this figure is still considered to be underestimatedbeacuse could be due both to inadequate attention and to the absence of specific subjective tools able to fully evaluate TAs in patients undergoing chemotherapy. Methods: A review by querying CINAHL, PubMed, Scopus and Google Scholar databases about the current status of use of the CiTAS self-evaluation scale, was performed. Results: From critical reading of the selected reports, it can be said that until now CiTAS has not been used to a large extent for evaluating taste, even at a late stage in patients undergoing chemotherapy. However, the results and the selected reports seem to indicate hope for its wider use. Conclusions: In literature, CITAS scale has been used on very heterogeneous populations and not adequately studied in specific care settings, its use within controlled trials could implement its spread.Correct and subjective evaluation of TAs would allow the planning of specific and personalized interventions aimed at providing adequate nutrition to support the maintenance and/or achievement of a correct body mass index. All this could contribute significantly to a better perception of QoL in patients undergoing chemotherapy. (www.actabiomedica.it).

Original languageEnglish
Pages (from-to)17-25
Number of pages9
JournalActa Biomedica
Volume90
DOIs
Publication statusPublished - Jul 9 2019

Fingerprint

Drug Therapy
Hope
Quality of Life
Diagnostic Self Evaluation
PubMed
Reading
Cause of Death
Body Mass Index
Therapeutics
Maintenance
Databases
Population
Neoplasms

Keywords

  • Cancer patients
  • Chemotherapy effect
  • CiTAS scale
  • Nutrition
  • Taste alteration

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The CiTAS scale for evaluating taste alteration induced by chemotherapy : State of the art on its clinical use. / Simeone, Silvio; Esposito, Maria Rosaria; Gargiulo, Gianpaolo; Lanzuise, Aniello; Botti, Stefano; Serra, Nicola; Continisio, Grazia Isabella; Rea, Teresa; Guillari, Assunta.

In: Acta Biomedica, Vol. 90, 09.07.2019, p. 17-25.

Research output: Contribution to journalArticle

Simeone, S, Esposito, MR, Gargiulo, G, Lanzuise, A, Botti, S, Serra, N, Continisio, GI, Rea, T & Guillari, A 2019, 'The CiTAS scale for evaluating taste alteration induced by chemotherapy: State of the art on its clinical use', Acta Biomedica, vol. 90, pp. 17-25. https://doi.org/10.23750/abm.v90i6-S.8278
Simeone, Silvio ; Esposito, Maria Rosaria ; Gargiulo, Gianpaolo ; Lanzuise, Aniello ; Botti, Stefano ; Serra, Nicola ; Continisio, Grazia Isabella ; Rea, Teresa ; Guillari, Assunta. / The CiTAS scale for evaluating taste alteration induced by chemotherapy : State of the art on its clinical use. In: Acta Biomedica. 2019 ; Vol. 90. pp. 17-25.
@article{96456a24c3aa4a43803a08bf5b794b0a,
title = "The CiTAS scale for evaluating taste alteration induced by chemotherapy: State of the art on its clinical use",
abstract = "Background: Cancer is the leading cause of death worldwide. Of the various therapeutic approaches, chemotherapy is the most widely used treatment. Among the various side effects associated with this treatment, taste alterations (TAs) have received little attention, even though they have a serious impact on the nutritional aspect and quality of life (QoL) of patients. TAs concern 75{\%} of the patients receiving chemotherapy, and this figure is still considered to be underestimatedbeacuse could be due both to inadequate attention and to the absence of specific subjective tools able to fully evaluate TAs in patients undergoing chemotherapy. Methods: A review by querying CINAHL, PubMed, Scopus and Google Scholar databases about the current status of use of the CiTAS self-evaluation scale, was performed. Results: From critical reading of the selected reports, it can be said that until now CiTAS has not been used to a large extent for evaluating taste, even at a late stage in patients undergoing chemotherapy. However, the results and the selected reports seem to indicate hope for its wider use. Conclusions: In literature, CITAS scale has been used on very heterogeneous populations and not adequately studied in specific care settings, its use within controlled trials could implement its spread.Correct and subjective evaluation of TAs would allow the planning of specific and personalized interventions aimed at providing adequate nutrition to support the maintenance and/or achievement of a correct body mass index. All this could contribute significantly to a better perception of QoL in patients undergoing chemotherapy. (www.actabiomedica.it).",
keywords = "Cancer patients, Chemotherapy effect, CiTAS scale, Nutrition, Taste alteration",
author = "Silvio Simeone and Esposito, {Maria Rosaria} and Gianpaolo Gargiulo and Aniello Lanzuise and Stefano Botti and Nicola Serra and Continisio, {Grazia Isabella} and Teresa Rea and Assunta Guillari",
year = "2019",
month = "7",
day = "9",
doi = "10.23750/abm.v90i6-S.8278",
language = "English",
volume = "90",
pages = "17--25",
journal = "Acta Biomedica de l'Ateneo Parmense",
issn = "0392-4203",
publisher = "L'Ateneo Parmense",

}

TY - JOUR

T1 - The CiTAS scale for evaluating taste alteration induced by chemotherapy

T2 - State of the art on its clinical use

AU - Simeone, Silvio

AU - Esposito, Maria Rosaria

AU - Gargiulo, Gianpaolo

AU - Lanzuise, Aniello

AU - Botti, Stefano

AU - Serra, Nicola

AU - Continisio, Grazia Isabella

AU - Rea, Teresa

AU - Guillari, Assunta

PY - 2019/7/9

Y1 - 2019/7/9

N2 - Background: Cancer is the leading cause of death worldwide. Of the various therapeutic approaches, chemotherapy is the most widely used treatment. Among the various side effects associated with this treatment, taste alterations (TAs) have received little attention, even though they have a serious impact on the nutritional aspect and quality of life (QoL) of patients. TAs concern 75% of the patients receiving chemotherapy, and this figure is still considered to be underestimatedbeacuse could be due both to inadequate attention and to the absence of specific subjective tools able to fully evaluate TAs in patients undergoing chemotherapy. Methods: A review by querying CINAHL, PubMed, Scopus and Google Scholar databases about the current status of use of the CiTAS self-evaluation scale, was performed. Results: From critical reading of the selected reports, it can be said that until now CiTAS has not been used to a large extent for evaluating taste, even at a late stage in patients undergoing chemotherapy. However, the results and the selected reports seem to indicate hope for its wider use. Conclusions: In literature, CITAS scale has been used on very heterogeneous populations and not adequately studied in specific care settings, its use within controlled trials could implement its spread.Correct and subjective evaluation of TAs would allow the planning of specific and personalized interventions aimed at providing adequate nutrition to support the maintenance and/or achievement of a correct body mass index. All this could contribute significantly to a better perception of QoL in patients undergoing chemotherapy. (www.actabiomedica.it).

AB - Background: Cancer is the leading cause of death worldwide. Of the various therapeutic approaches, chemotherapy is the most widely used treatment. Among the various side effects associated with this treatment, taste alterations (TAs) have received little attention, even though they have a serious impact on the nutritional aspect and quality of life (QoL) of patients. TAs concern 75% of the patients receiving chemotherapy, and this figure is still considered to be underestimatedbeacuse could be due both to inadequate attention and to the absence of specific subjective tools able to fully evaluate TAs in patients undergoing chemotherapy. Methods: A review by querying CINAHL, PubMed, Scopus and Google Scholar databases about the current status of use of the CiTAS self-evaluation scale, was performed. Results: From critical reading of the selected reports, it can be said that until now CiTAS has not been used to a large extent for evaluating taste, even at a late stage in patients undergoing chemotherapy. However, the results and the selected reports seem to indicate hope for its wider use. Conclusions: In literature, CITAS scale has been used on very heterogeneous populations and not adequately studied in specific care settings, its use within controlled trials could implement its spread.Correct and subjective evaluation of TAs would allow the planning of specific and personalized interventions aimed at providing adequate nutrition to support the maintenance and/or achievement of a correct body mass index. All this could contribute significantly to a better perception of QoL in patients undergoing chemotherapy. (www.actabiomedica.it).

KW - Cancer patients

KW - Chemotherapy effect

KW - CiTAS scale

KW - Nutrition

KW - Taste alteration

UR - http://www.scopus.com/inward/record.url?scp=85069546111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069546111&partnerID=8YFLogxK

U2 - 10.23750/abm.v90i6-S.8278

DO - 10.23750/abm.v90i6-S.8278

M3 - Article

C2 - 31292411

AN - SCOPUS:85069546111

VL - 90

SP - 17

EP - 25

JO - Acta Biomedica de l'Ateneo Parmense

JF - Acta Biomedica de l'Ateneo Parmense

SN - 0392-4203

ER -